Citius Pharma Announces Offering of 10.15M Shares & Warrants

Citius Pharmaceuticals, Inc. entered into a securities purchase agreement for a registered direct offering and a concurrent private placement. The registered direct offering includes 4,730,457 shares of common stock at $0.985 per share and 345,686 pre-funded warrants at $0.9849. Concurrently, the company will sell warrants to purchase up to 5,076,143 common shares in a private placement, with an exercise price of $0.86 per share. This capital raise aims to strengthen the company's financial position.